251120 — Bio-FD&C Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩143bn
- KR₩103bn
- KR₩16bn
- 79
- 26
- 84
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,508 | 5,494 | 5,485 | 40,329 | 40,882 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 915 | 978 | 2,027 | 2,266 | 2,987 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8,583 | 7,867 | 9,173 | 44,894 | 45,726 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,333 | 7,670 | 13,091 | 12,217 | 13,263 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 15,291 | 17,626 | 23,040 | 59,036 | 62,813 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,299 | 3,436 | 6,751 | 5,981 | 4,091 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5,327 | 5,202 | 7,157 | 6,058 | 4,196 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 9,963 | 12,425 | 15,883 | 52,977 | 58,617 |
Total Liabilities & Shareholders' Equity | 15,291 | 17,626 | 23,040 | 59,036 | 62,813 |
Total Common Shares Outstanding |